Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.49), $0.10 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.